Boxed Warning section
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in subjects over age 24; there was a reduction in risk with antidepressant use in subjects aged 65 and older [see Warnings and Precautions ].
In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber [see Warnings and Precautions].
NEUROPSYCHIATRIC REACTIONS IN PATIENTS TAKING BUPROPION FOR SMOKING CESSATION
Serious neuropsychiatric reactions have occurred in patientstaking bupropion for smoking cessation [see Warnings and Precautions ]. The majority of these reactions occurred during bupropion treatment, but some occurred in the context of discontinuing treatment. In many cases, a causal relationship to bupropion treatment is not certain, because depressed mood may be a symptom of nicotine withdrawal. However, some of the cases occurred in patients taking bupropion who continued to smoke. Although WELLBUTRIN® is not approved for smoking cessation, observe all patients for neuropsychiatric reactions. Instruct the patient to contact a healthcare provider if such reactions occur [seeWarnings and Precautions].
WELLBUTRIN (bupropion hydrochloride), an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin re?uptake inhibitor, or other known antidepressant agents.
WELLBUTRIN (bupropion hydrochloride)is indicated for the treatment of major depressive disorder(MDD), as defined by the Diagnostic and Statistical Manual (DSM ).
The efficacy of WELLBUTRIN in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies].
Published Studies Related to Wellbutrin (Bupropion)
SSRI versus bupropion effects on symptom clusters in suicidal depression: post
hoc analysis of a randomized clinical trial. 
CONCLUSIONS: The results require replication but suggest a pathway by which
Bupropion for smoking cessation in patients hospitalized with acute myocardial
infarction: a randomized, placebo-controlled trial. 
patients with acute myocardial infarction (AMI)... CONCLUSIONS: Two-thirds of patients return to smoking by 12 months after AMI.
The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence. 
cognitive-behavioral mood management therapy... CONCLUSIONS: VNTR by treatment interaction differences between these and previous
Sustained-release bupropion for smoking cessation in a Chinese sample: a
double-blind, placebo-controlled, randomized trial. 
population... CONCLUSION: Bup-SR is efficacious for smoking cessation in healthy Chinese
The DRD4 Exon III VNTR, Bupropion, and Associations With Prospective Abstinence. 
cognitive-behavioral mood management therapy... CONCLUSIONS: VNTR by treatment interaction
Clinical Trials Related to Wellbutrin (Bupropion)
Wellbutrin XL, Major Depressive Disorder and Breast Cancer [Completed]
- To evaluate the efficacy of bupropion extended release (Wellbutrin XL™) in the treatment
of Major Depressive Disorder in women with breast cancer.
- To evaluate the tolerability of bupropion extended-release (Wellbutrin XL™) in these
The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity [Completed]
The purpose of the study is to evaluate the effects of a single-dose of Wellbutrin XL
(bupropion hydrochloride) on reward processing.
Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions [Recruiting]
The objective of this study is to evaluate the comparative bioavailability between bupropion
hydrochloride 300 mg extended release tablets (Teva Pharmaceuticals USA) and Wellbutrin XL®
300 mg extended release tablets (Biovail Pharmaceuticals, Inc.) at steady-state in patients
under fasting conditions.
Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial [Recruiting]
Patients who continue to smoke after a heart attack have a 35% increased risk of a recurrent
event or death compared with those who quit. Many patients attempt to stop smoking after a
heart attack, but relapse rates approach 66%. A variety of smoking cessation aids have been
shown to be effective for the general population. However, bupropion is the only
non-nicotine replacement therapy shown to improve abstinence rates in healthy young smokers.
Furthermore, nicotine replacement therapies (NRTs) are contraindicated in the immediate
period following a heart attack because of the undesirable effects of nicotine. Although
bupropion has been successfully used to reduce smoking rates in healthy young populations,
its efficacy and safety in the setting of patients recovering from an ACS is unknown. These
patients, if they continue to smoke, are at exceptionally high risk for recurrent cardiac
events. If bupropion is effective in this population, it will have a major impact on
secondary prevention of recurrent clinical events in patients who suffer a heart attack.
The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior [Recruiting]
The purpose of this study is to examine how smoking cessation medications (varenicline,
bupropion) affect the ability to resist smoking and also subsequent ad-lib smoking in
non-treatment seeking daily smokers.
Reports of Suspected Wellbutrin (Bupropion) Side Effects
Drug Ineffective (103),
Suicidal Ideation (32),
Weight Increased (27),
Feeling Abnormal (25),
Insomnia (23), more >>
PATIENT REVIEWS / RATINGS / COMMENTS
Based on a total of 42 ratings/reviews, Wellbutrin has an overall score of 7.19. The effectiveness score is 7.43 and the side effect score is 7.48. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.
Wellbutrin review by 27 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Considerably Effective|
|Side effects:|| || Mild Side Effects|
|Condition / reason:|| || Depression|
|Dosage & duration:|| || 300mg / day taken 2x daily for the period of I have been on it for 6 years now|
|Other conditions:|| || Inreased sweating at night, mild dehydration, trouble sleeping at times|
|Other drugs taken:|| || Celexia|
|Benefits:|| || I began taking the drug to control my Bulimia, which was the main symptom of my depression. It also helped me stop smoking.|
|Side effects:|| || Very few. I noticed right away that I had trouble sleeping from my high dosage. My ddoctor then prescribed 40mg / day of Celexia to counteract the restlessness.|
|Comments:|| || After about 1 month of taking the drug, the bingeing and purging decreased greatly. (from maybe 4 or 5 times /day to about once a month, if that. After 6 years of being on the medication, my Bulimia is under control and depression seems situational.|
Wellbutrin review by 40 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Considerably Effective|
|Side effects:|| || No Side Effects|
|Condition / reason:|| || Bipolar Disorder II|
|Dosage & duration:|| || 100 mg taken 2x daily for the period of 6 Years|
|Other conditions:|| || None|
|Other drugs taken:|| || Topomax|
|Benefits:|| || I had a nervous breakdown suddenly and unexpectedly. After 1 week in the psych ward, I was prescribed 2 medications that I soon realized didn't help. Over the course of 1 year, I tried many different combinations of anti-depresants which didn't work. Not until I tried both wellbutrin and topomax together did I start recovering from my breakdown. About 1 1/2 years ago I discontinued the Topomax and I've only used the Wellbutrin since it helps me maintain my health. |
|Side effects:|| || I didn't experience any side effects.|
|Comments:|| || See above as that thoroughly explains everything.|
Wellbutrin review by 37 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Ineffective|
|Side effects:|| || Extremely Severe Side Effects|
|Condition / reason:|| || Anxety / Depression |
|Dosage & duration:|| || 150mg taken daily / 150mg in morning for the period of 1 month|
|Other conditions:|| || sexual dysfunction |
|Other drugs taken:|| || birth control, Hydrochlorothiadzide|
|Benefits:|| || I only started this medication to still treat my Anxiety and mild depression, but eliminate the desire not to want sex. |
|Side effects:|| || Irritable, sleeplessness, rages of angry, fatigue, high blood pressure|
|Comments:|| || My OBGYN switched me from Prozac to Wellbutrin in efforts to help with the sexual side affects. Well, it did absolulte nothing to help in that area and instead made me more depressed, irritable, had severe rages, crying all the time, no desire to get out of bed, hot flashes and my blood pressure spiked tremendously. I went back to my PCP and I'm back to Zoloft which I had taken in the past and although I'm still having w/d's from the Wellbutrin, I'm felling 80% better in it's only been 3 days. I tossed all the remaining pills out. This drug clearly didn't work for my body. What a horrible experience to go through. I will in the future only get these types of meds from my PCP and not my OBGYN. |
Page last updated: 2014-11-30